A detailed history of Stokes Family Office, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Stokes Family Office, LLC holds 24,840 shares of ABT stock, worth $2.84 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
24,840
Previous 24,838 0.01%
Holding current value
$2.84 Million
Previous $2.58 Million 9.77%
% of portfolio
0.32%
Previous 0.31%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $200 - $236
2 Added 0.01%
24,840 $2.83 Million
Q2 2024

Jul 05, 2024

BUY
$100.73 - $112.44 $25,383 - $28,334
252 Added 1.02%
24,838 $2.58 Million
Q1 2024

May 06, 2024

SELL
$109.52 - $120.96 $19,385 - $21,409
-177 Reduced 0.71%
24,586 $2.79 Million
Q4 2023

Feb 06, 2024

SELL
$90.19 - $110.4 $538,704 - $659,419
-5,973 Reduced 19.43%
24,763 $2.73 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $36,683 - $44,014
-384 Reduced 1.23%
30,736 $2.98 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $64,297 - $71,641
638 Added 2.09%
31,120 $3.39 Million
Q1 2023

May 08, 2023

SELL
$96.86 - $114.01 $99,087 - $116,632
-1,023 Reduced 3.25%
30,482 $3.09 Million
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $75,192 - $88,212
-791 Reduced 2.45%
31,505 $3.46 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $24,673 - $28,567
255 Added 0.8%
32,296 $3.13 Million
Q2 2022

Aug 05, 2022

BUY
$102.07 - $123.37 $24,190 - $29,238
237 Added 0.75%
32,041 $3.48 Million
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $2,964 - $3,615
26 Added 0.08%
31,804 $3.76 Million
Q4 2021

Feb 15, 2022

BUY
$115.53 - $141.46 $87,109 - $106,660
754 Added 2.43%
31,778 $4.47 Million
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $17,965 - $19,875
154 Added 0.5%
31,024 $3.67 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $5,395 - $6,351
51 Added 0.17%
30,870 $3.58 Million
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $8,924 - $10,514
82 Added 0.27%
30,819 $3.7 Million
Q4 2020

Feb 10, 2021

BUY
$105.0 - $114.42 $137,655 - $150,004
1,311 Added 4.46%
30,737 $3.37 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $129,578 - $157,364
-1,414 Reduced 4.58%
29,426 $3.2 Million
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $76,340 - $97,706
-997 Reduced 3.13%
30,840 $2.82 Million
Q1 2020

May 12, 2020

BUY
$62.82 - $91.86 $102,585 - $150,007
1,633 Added 5.41%
31,837 $2.51 Million
Q4 2019

Feb 10, 2020

BUY
$78.51 - $87.4 $2.37 Million - $2.64 Million
30,204 New
30,204 $2.62 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Stokes Family Office, LLC Portfolio

Follow Stokes Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.